• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-04-23 15:30 原文鏈接: Transcription,TranslationofS35RadiolabelledProteinandBindingtoGST

    1. Prepare the template by linearizing 25ug plasmid DNA at the 3'' end of the insert. Phenol / chloroform extract, ethanol / NaCl precipitate and resuspend in 25ul DDW

    2. Transcription Reaction:

      Reagentamt / reaction
      5x transcription buffer20ul
      10 x DDT10ul
      DDW40ul
      rNTP20ul
      RNasin0.5ul
      T7RNA polymerase1ul

      Add to 5ug DNA template. Mix reaction, adding enzyme (T7) last. 
      Incubate 37°C 90 min

    3. Add equal volume phenol/chloroform (100ul). Vortex. Spin 13000 rpm 2 min

    4. Add supernatant to new eppendorf and ethanol precipitate 2.5 vol ethanol and 0.3M NaCl final conc..

    5. Resuspend 25 ul TE

    6. Run 3ul RNA on Northern gel to check the template.

    Northern

    -1.5g agarose in 130ml DDW. Boil to dissolve agarose and add 15ml 10 x MOPS. Cool and add 15ml formaldehyde. Add 3ul RNA and 7ul Sample buffer. Sample buffer (90ul total) = 50ul deionized formamide, 20ul formaldehyde, 10ul 10 x MOPS and 10ul 400 ug / ml Ethidium Bromide
    -Heat RNA 65oC 10 min
    -Run at 100v 2 hrs in 1 x MOPS. The sample should contain 0.2-1.0ug RNA.

     

    Translation

    We use Promega rabbit reticulocyte lysate. S35 methionine is DuPont translation grade (5mCi/mmol)

    1. Heat RNA 60°C 5 min, ice and prepare reaction cocktail. The lysate can be refrozen once. Only prepare a cocktail with the amount required.

      • Lysate 200ul

      • DDW 55 ul

      • RNasin 4 ul

      • AA-met 6 ul

      • 35S met 25 ul

      • For example:

    2. Add 50ul reaction mix to 5ul RNA

    3. Incubate 30°C 60 min. Freeze - 20oC

    Binding to purified GEX fusion proteins or antisera

    1. Combine 15ul lysate with 5ul fused protein (2mg/ml) or 5ul antisera in 0.5ml PLC basic lysis buffer (see Appendix)

    2. Incubate ice 1 hr

    3. Swell 2mg Glutathione agarose beads (Sigma G-4510) or 2.5mg protein A sepharose (for antisera, P-3391, Sigma) per sample in PLC buffer / 10mM DTT and resuspend beads 0.1 ml PLC buffer per sample. Add 0.1ml of beads per sample and incubate on a wheel at 4°C for 1hr.

    4. Add 100ul bead suspension / binding reaction and place of the wheel at 4oC for 1 hr

    5. Pellet samples in ependorf for 30 sec and remove s/n to last 50ul with a blue tip. Add ice cold PLC -lysis buffer and vortex.

    6. Repeat 3 x, then aspirate all buffer from beads with Gilson pipette

    7. Add 40ul SDS sample buffer

    8. Run on SDS PAGE gel.

    9. Stain with Coomassie and destain. Photograph gel to check recovery of GST proteins or antibody heavy chain with beads.

    10. Amplify (Amersham RPN 2106) 30 min, dry and autoradiograph

    Testing protein-protein interactions with in vitro transcribed and translated proteins.

    The two proteins should be translated such that one is labelled with 35S methionine and one is unlabelled. If binding is to be assayed by Immunoprecipitation, then the "bait" protein to which the precipitating antibody is directed should be unlabelled and the "target" protein labelled. Having the two proteins labelled is possible, but probably best avoided to keep the amount of label down, and in cases where "target" protein and "bait" proteins are the same size. A control with vector only as "bait" should be used to show non-specific binding of labelled proteins to the beads. If background is a problem, then blocking agents such as 5% skim milk powder or 0.8% BSA could be used. Preclearing the immunoprecipitation with protein A/G sepharose is also a possibility.

    1. Prepare proteins separately by in vitro transcription and translation according to the standard Promega TNT reticulocyte protocol. Adjust total reaction volume so there is 12.5ul of each lysate per binding assay.

    2. Add 12.5ul of each protein lysate to an eppendorf and mix by pipetting. Allow proteins to associate for 30 minutes at 4°C.

    3. Add 200ul of cold immunoprecipitation buffer. Suitable buffers include basic PLC (with or without EGTA), RIPA buffer (with or without SDS) and PBS with 0.01% lubrol. Choice of buffer is dependant on the strength of interaction. Probably the gentlest conditions are PBS with lubrol. Be aware that some protein-protein interactions may be dependant on metal ions such as zinc, and these should be supplemented where appropriate.

    4. Add antisera (5-10ul crude sera) and 2.5mg protein A/G sepharose. Incubate overnight at 4°C with gentle agitation.

    5. Spin down beads and wash three times in 1ml of immunoprecipitation buffer. The first wash should be carried out in the hood and the radioactive waste discarded appropriately.

    6. Resuspend beads in 30ul SDS sample buffer and run 20ul on a polyacrylamide gel. Dry gel down and autoradiograph.


    相關文章

    因美納推出Illumina?ProteinPrep,驅動更深入的蛋白質組學洞察,助力藥物發現與開發

    IlluminaProteinPrep可檢測9,500種獨特的人類蛋白質靶標,為蛋白質生物學提供全新洞察,推動疾病治療新發現早期試用客戶充分認可了其大規模檢測能力、高度一致性以及簡便的“從樣本到洞察”......

    美國TO設備助陣,第六屆上海市力學競賽團體賽圓滿成功

    2024年11月9日,由上海市力學學會主辦、同濟大學承辦的第六屆上海市大學生力學競賽團體賽在同濟大學舉行。來自同濟大學、上海交通大學、復旦大學、華東師范大學、上海大學、上海工程技術大學、上海師范大學、......

    190億!賽默飛收購歐洲IVD巨頭

    近日,服務科學領域的全球領導者賽默飛世爾科技(以下簡稱賽默飛)宣布,在達成收購意向兩個月之后,賽默飛以28億美元、折合人民幣約190億元的價格,完成了對TheBindingSiteGroup的全現金收......

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    ProteinCell:病毒感染時翻譯后修飾乙酰化的動態調控

    天然免疫應答是機體應對病原微生物入侵的第一道防線,在殺傷病原微生物、清除感染細胞和維持體內穩態等方面發揮關鍵作用。蛋白質翻譯后修飾(proteinpost-translationalmodificat......

    Protein&Cell丨劉平生團隊發現脂滴和線粒體相互錨定接觸

    脂滴是一種具有中性脂質核心的膜性細胞器。與其他膜性細胞器的根本區別就是脂滴由單分子磷脂膜包被,而其他膜性細胞器由雙分子磷脂膜與外界隔離。脂滴最早由列文虎克于1674年在牛奶里發現,是人類最早發現的膜性......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频